Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United StatesBusiness Wire • 03/08/21
Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance ConferenceBusiness Wire • 03/01/21
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/10/21
Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock?Zacks Investment Research • 02/09/21
Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United StatesBusiness Wire • 01/14/21
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 39th Annual JP Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/21
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021Business Wire • 01/08/21
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with SchizophreniaBusiness Wire • 01/07/21